BlossomHill Therapeutics (BLSM) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 21 65 sessions, August 7, 2026 to November 6, 2026
- Largest daily move
- +18.4% close of September 16, 2026
- 1-month change
- -21.9% closing prices, October 6, 2026 to November 6, 2026
Company Description
BlossomHill Therapeutics (NASDAQ: BLSM) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $429.1M.
BLSM has declined 21.9% over the past month. The last closing price was $13.50.
This page collects what Stock Titan holds for BLSM, including price data, latest news, SEC filings, insider trading activity, upcoming events, and short interest trends.
Stock Performance
BlossomHill Therapeutics (BLSM) closed at $13.50 on November 6, 2026. Over the past month, the price has lost 21.9%.
BLSM Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
BlossomHill Therapeutics has 10 recent news articles, with the latest published 3 days ago. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, partnership, earnings, clinical trial, IPO. View all BLSM news →
SEC Filings
BlossomHill Therapeutics has filed 10 recent SEC filings, including 3 Form 4, 2 Form 8-K, 2 Form SCHEDULE 13D, 2 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BLSM SEC filings →
Insider Radar
Insider buying activity at BlossomHill Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Fireside chat
ASH poster presentation
IND submission
Global Phase 2 Trial
BlossomHill Therapeutics has 4 upcoming scheduled events. The next event, "Fireside chat", is scheduled for November 10, 2026 (in 3 days). Investors can track these dates to stay informed about potential catalysts that may affect the BLSM stock price.
Short Interest History
Short interest in BlossomHill Therapeutics (BLSM) currently stands at 485.0 thousand shares, up 2.4% from the previous reporting period, representing 2.1% of the float. Since August 2026, short interest has increased by 333.4%.
Days to Cover History
Days to cover for BlossomHill Therapeutics (BLSM) currently stands at 2.9 days, up 77.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since August 2026, the figure has increased by 187%. Across the settlements charted above, it has ranged from 1.0 to 2.9 days.
BLSM Company Profile & Sector Positioning
BlossomHill Therapeutics (BLSM) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing BLSM often look at related companies in the same sector, including Altimmune, Inc. (ALT), Allogene Therapeutics, Inc. (ALLO), Assembly Biosciences, Inc (ASMB), Editas Medicine, Inc. (EDIT), and Rezolute, Inc. (RZLT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BLSM's relative position within its industry.